Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Published:2014-04 Issue: Volume: Page:237
ISSN:1178-2048
Container-title:Vascular Health and Risk Management
language:en
Short-container-title:VHRM

Author:

Marrett Elizabeth,Zhao Changgeng,Zhang Ning Jackie,Zhang Qiaoyi,Ramey Dena,Tomassini Joanne,Tershakovec Andrew,Neff David

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health,Hematology,General Medicine,Endocrinology, Diabetes and Metabolism

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for carotid plaque formation in type 2 diabetes mellitus;Journal of Translational Medicine;2024-01-04

2. Clinical characteristics and treatment patterns in patients with atherosclerotic cardiovascular disease with hypercholesterolemia: a retrospective analysis of a large US real-world database cohort;Current Medical Research and Opinion;2023-11-23

3. DRP1 knockdown and atorvastatin alleviate ox-LDL-induced vascular endothelial cells injury: DRP1 is a potential target for preventing atherosclerosis;Experimental Cell Research;2023-08

4. Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial;Atherosclerosis;2021-03

5. Response to statin therapy in the real world;European Journal of Preventive Cardiology;2020-02-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP